Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cobalis Corp.
Cobalis Corp Gets Federal Court Approval to Launch Its Flagship Anti-Allergy Product PreHistin™
January 31st, 2009
Cobalis Corp. (OTC:CLSC), a pharmaceutical biotech Company specializing in the development of anti-allergy medications, announced the planned marketing launch of the flagship anti-allergy product PreHistin™ after approval in Federal Court in Santa Ana, CA on Jan. 13, 2009. The launch of PreHistin™ is scheduled for February 2009, and will enable the company to be discharged from Chapter 11. Cobalis Corp. has conducted numerous clinical trials in over 30 board certified clinics with physicians throughout the U.S. with over 2200 patients in the Phase III trials of PreHistin™. The Company has demonstrated that pre seasonal treatment with PreHistin™ was seen to clearly...
Source: Law & Health Weekly (2009-01-31)
|
